- Login
- Register & Subscribe
- Language: EN FR DE
Finance, Grants, Deals
Watson pays $150 million upfront for Uteron Pharma
Wednesday 23 January 2013
Watson Pharmaceuticals Inc has agreed to pay $150 million upfront for Uteron Pharma SA, a Belgian producer of healthcare products for women. The deal also includes up to $155 million in potential future milestone payments.
Location
United States
Cytos takes back smoking cessation vaccine
Wednesday 23 January 2013
Cytos Biotechnology Ltd said that it is reclaiming a vaccine asset that had been licensed to Novartis for the treatment of nicotine addiction following the failure of a Phase 2 trial. The product is a therapeutic vaccine.
Location
Switzerland
Lophius raises €4 million for T-cell diagnostics
Tuesday 22 January 2013
Lophius Biosciences GmbH has raised nearly €4 million from existing shareholders and new shareholders to finance development of diagnostics based on T-cell technology.
Location
Germany
Life Technologies acquires Dutch BAC BV
Tuesday 22 January 2013
Life Technologies Corp of the US has announced the acquisition of privately-owned BAC BV of the Netherlands which specialises in the development and manufacture of protein purification products. The deal will expand the US company’s capabilities in bioprocessing.
Location
United States
Prexton gets option on PD compounds
Tuesday 22 January 2013
Prexton Therapeutics SA of Geneva Switzerland has negotiated an exclusive option for a series of positive allosteric modulator drugs targeting Parkinson’s disease with the goal of progressing them into clinical development. The agreement is with Domain Therapeutics SA of France.
Location
France
Galápagos acquires UK structure-based discovery company
Tuesday 15 January 2013
Galápagos NV of Belgium will be adding structure-based drug discovery to its stable of technologies with the acquisition of Cangenix Ltd, a UK start-up that was created by scientists from the former Pfizer Inc subsidiary in Sandwich UK.
Location
Belgium
Biotec Pharmacon raises NOK 40 mln in placement
Friday 11 January 2013
Biotech Pharmacon ASA of Norway has announced the successful placement of 9.5 million new shares with private investors thereby raising NOK 40 million (€5.45 million) in gross proceeds for product launch and development.
Location
Norway
Shire to acquire Lotus Tissue Repair
Tuesday 8 January 2013
Shire Plc has taken further steps to strengthen its franchise in rare diseases with an agreement to acquire privately-owned Lotus Tissue Repair Inc which has a preclinical product for the treatment of dystrophic epidermolysis bullosa (DEB). Financial terms were not disclosed.
Location
United Kingdom
ArGEN-X starts cancer study; broadens alliance with Shire
Monday 7 January 2013
ArGEN-X BV has announced the initiation of a Phase 1b clinical study in cancer patients of a new antibody targeting CD70, a member of the tumour necrosis factor superfamily. The company also announced an expansion of its discovery alliance with Shire Plc.
Location
Netherlands
ISA Pharmaceuticals secures €8 million
Monday 7 January 2013
ISA Pharmaceuticals BV of the Netherlands has secured €8 million in funding from the Aglaia Oncology Fund and private investors to finance a Phase 2 study of its lead therapeutic vaccine candidate in cervical cancer. This a follow-on to an earlier Series A round.
Location
Netherlands
Select a News Category
Recent Appointments
Pascale Witz to head strategic development at Sanofi
Monday May 6 2013
Srinivas Akkaraju joins Sofinnova Ventures
Monday May 6 2013
Vicente Anido nominated to Nicox board
Monday May 6 2013
Jeremy Farrar named director of the Wellcome Trust
Monday May 6 2013
Harry Kirsch becomes CFO at Novartis
Monday May 6 2013